WARSAW —  WishBone Medical held its first shareholder meeting since the founding of the company in January. Investors, employees and guests were given an overall view of WishBone Medical’s fast start at the global headquarters in Warsaw.

CEO and Founder Nick Deeter was re-elected unanimously as chairman of the board. CEO Marlin Stutzman and Mary Wetzel were re-elected unanimously as president and chief operating officer respectively by the Board of Directors following the shareholder meeting.  Marlin Stutzman and Mary Wetzel will also remain on the board of directors.  Three outside shareholders will continue serving on the WishBone Medical Board of Directors; Andy Miclot, J. Pat Richardson and Lynnette Jackson.

“Our team has been working very hard since the beginning of 2017 and together, we have been able to reach the goals that were set forth when the formation of WishBone Medical started late 2016,” Deeter explains.  “Our shareholders walked away from our meeting feeling very comfortable knowing that WishBone Medical has set out to accomplish the tasks that the company said it would, including a very aggressive new product launch schedule.”

WishBone Medical’s focus is the pediatric orthopedic industry and has rolled out its first product, Exact Osteotomy System, in June 2017, which was within the first six months of operation. WishBone Medical plans to roll out nine more product systems this year, which is unprecedented for new orthopedic companies. 

Shareholders had the opportunity to meet the team that has been assembled this past year and to learn of the rollout and pipeline for products to come into the marketplace late 2017 and in 2018.

“I have been involved with WishBone Medical as a director and advisor since its inception,” says J. Pat Richardson. “WishBone Medical started pushing revenue and eliminating unneeded costs from day one.” Richardson went on to add, “this fast to market revenue, with a minimal inventory business model, is a paradigm shift in the industry.”

WishBone Medical Inc. continues to grow rapidly in a market that is in desperate need of anatomically appropriate pediatric orthopedic devices in their distribution model of single use sterile pack disposable kits.